We are live on
!
Find out more
SCM
Scopia Capital Management Portfolio holdings
AUM
$146M
1-Year Est. Return
25.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.67%
1 Year Est. Return
+25.93%
3 Year Est. Return
+30.87%
5 Year Est. Return
+45.28%
10 Year Est. Return
+379.83%
AUM
$5.28B
AUM Growth
-$391M
(-6.9%)
Cap. Flow
-$564M
Cap. Flow
% of AUM
-10.68%
Top 10 Holdings %
Top 10 Hldgs %
63.93%
Holding
51
New
10
Increased
14
Reduced
8
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$147M |
| 2 |
TMH
Team Health Holdings Inc
TMH
|
+$138M |
| 3 |
Signet Jewelers
SIG
|
+$111M |
| 4 |
iShares MSCI Japan ETF
EWJ
|
+$107M |
| 5 |
FCE.A
Forest City Realty Trust, Inc.
FCE.A
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$279M |
| 2 |
SPR
Spirit AeroSystems
SPR
|
+$248M |
| 3 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$116M |
| 4 |
DST
DST Systems Inc.
DST
|
+$112M |
| 5 |
United Therapeutics
UTHR
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.85% |
| 2 | Industrials | 17.68% |
| 3 | Communication Services | 13.09% |
| 4 | Technology | 9.65% |
| 5 | Real Estate | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
PUT
iShares Biotechnology ETF
IBB
$9.45B
| $48.8M | 0.92% |
551,100
-882,900
| -62% | -$80.4M |
|
|
AAAP
27
DELISTED
Advanced Accelerator Applications S.A.
AAAP
| $47.7M | 0.9% |
1,782,782
+1,071,256
| +151% | +$36M |
|
28
Dycom Industries
DY
$11.2B
| $47.5M | 0.9% |
+591,701
| New | +$47.9M |
|
29
Generac Holdings
GNRC
$11.5B
| $46M | 0.87% |
1,129,536
| – | – |
|
30
Trinity Industries
TRN
$2.92B
| $43.5M | 0.82% |
2,177,891
| – | – |
|
31
Fair Isaac
FICO
$31.8B
| $34.1M | 0.65% |
286,351
-423,879
| -60% | -$50.4M |
|
|
JUNO
32
DELISTED
Juno Therapeutics, Inc.
JUNO
| $33.5M | 0.64% |
+1,778,724
| New | +$43.5M |
|
33
Tractor Supply
TSCO
$16.3B
| $29.1M | 0.55% |
1,916,190
+1,530,175
| +396% | +$21.7M |
|
|
SLCA
34
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $14.1M | 0.27% |
248,911
| – | – |
|
|
MYOV
35
DELISTED
Myovant Sciences Ltd.
MYOV
| $10.2M | 0.19% |
+817,747
| New | +$9.48M |
|
|
NVLN
36
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
| $9.85M | 0.19% |
+1,169,912
| New | +$10.4M |
|
|
I
37
DELISTED
INTELSAT S. A.
I
| $5.45M | 0.1% |
2,042,666
-9,536
| -0.5% | -$28.9K |
|
38
Prospect Capital
PSEC
$1.08B
| $870K | 0.02% |
104,194
| – | – |
|
39
American Superconductor
AMSC
$1.29B
| – | – |
-19,610
| Closed | -$137K |
|
40
Boeing
BA
$169B
| – | – |
-304,927
| Closed | -$40.2M |
|
41
Fossil Group
FOSL
$260M
| – | – |
-395,925
| Closed | -$11M |
|
42
The Greenbrier Companies
GBX
$1.57B
| – | – |
-285,846
| Closed | -$10.1M |
|
43
MannKind Corp
MNKD
$1.19B
| – | – |
-982,928
| Closed | -$3.05M |
|
44
Myriad Genetics
MYGN
$476M
| – | – |
-3,659,647
| Closed | -$75.3M |
|
45
CALL
Netflix
NFLX
$307B
| – | – |
-5,000,000
| Closed | -$49.3M |
|
|
46
Perrigo
PRGO
$1.44B
| – | – |
-3,022,503
| Closed | -$279M |
|
47
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
| – | – |
-1,661,000
| Closed | -$359M |
|
48
Wabtec
WAB
$49.3B
| – | – |
-120,648
| Closed | -$9.85M |
|
|
TMX
49
DELISTED
Terminix Global Holdings, Inc.
TMX
| – | – |
-5,131,013
| Closed | -$116M |
|
|
AEGR
50
DELISTED
Aegerion Pharmaceuticals
AEGR
| – | – |
-5,703,587
| Closed | -$16.9M |
|
Similar funds
AWM
SIM
TA
2L
AFM
ECM
CWM
CCM
Scopia Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Scopia Capital Management held 51 positions worth $5.28B, down 6.9% from $5.67B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Scopia Capital Management withdrew a net $564M in Q4 2016, closing 13 positions and reducing 8 holdings. Its most notable exit was Perrigo, an estimated $279M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, Scopia Capital Management opened a new position in Horizon Therapeutics Public Limited Company Ordinary Shares worth $131M.
- Scopia Capital Management's largest Q4 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 8,081,650 shares worth $131M.
- Scopia Capital Management added most to Forest City Realty Trust, Inc. in Q4 2016, an estimated $103M increase.
- Scopia Capital Management's biggest Q4 2016 reduction was Spirit AeroSystems, cutting an estimated $248M.
- Scopia Capital Management fully exited Perrigo in Q4 2016, selling an estimated $279M.
- Scopia Capital Management's ten largest holdings make up 64% of its $5.28B portfolio in Q4 2016.
- Scopia Capital Management opened 10 new positions and closed 13 in Q4 2016.
- Scopia Capital Management's portfolio value fell 6.9% quarter-over-quarter to $5.28B.
Based on Scopia Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.